2011
DOI: 10.1124/jpet.110.172635
|View full text |Cite
|
Sign up to set email alerts
|

A View on Imaging in Drug Research and Development for Respiratory Diseases

Abstract: With the incidence of respiratory diseases increasing throughout the world, new therapies are needed. This review provides a short overview of different imaging techniques of interest for drug discovery and development within the pulmonary disease area. The focus is on studies performed in both animals and humans, which are of importance for understanding pathophysiological aspects and evaluating new drugs. Rather than emphasizing particular lung diseases, the noninvasive diagnosis and quantification of a numb… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
8
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 138 publications
2
8
0
Order By: Relevance
“…The technique has been used to examine bleomycin‐induced lung injury in mice (42, 43). Interestingly, the responses detected in the lungs using micro‐CT were qualitatively similar to those reported here, and both techniques showed images of similar quality (44). A considerable limitation of the micro‐CT studies is the use of radiation doses that are even higher than those adopted in clinical medicine.…”
Section: Discussionsupporting
confidence: 79%
“…The technique has been used to examine bleomycin‐induced lung injury in mice (42, 43). Interestingly, the responses detected in the lungs using micro‐CT were qualitatively similar to those reported here, and both techniques showed images of similar quality (44). A considerable limitation of the micro‐CT studies is the use of radiation doses that are even higher than those adopted in clinical medicine.…”
Section: Discussionsupporting
confidence: 79%
“…A three-dimensional (3D) ultrashort echo time (UTE) sequence (49,50,56,60) with the following parameters was used for acquisitions on rats and mice (whenever different, parameters for mice are provided in parentheses): repetition time (TR) 2.7 ms, echo time 0.02 ms, flip angle of the excitation pulse 2°(3°), 51360 (77086) projections, field-of-view (FOV) 50 ϫ 50 ϫ 70 (30 ϫ 30 ϫ 50) mm 3 , matrix 128 ϫ 128 ϫ 128 (192 ϫ 192 ϫ 192), 5 (2) averages. The acquisition times for the 3D acquisitions were of 11.6 and 6.9 min for rats and mice, respectively.…”
Section: Methodsmentioning
confidence: 99%
“…Nanoscale particles and carriers have already demonstrated effective applications in the diagnosis of diseases. In addition, some of these nanocompounds, commonly known as theranostic agents, have also shown efficient results in the therapy of these pathologies . Nanoparticles have been reported to be efficacious in anti‐angiogenesis therapy , immunotherapy , and gene therapy of GBM .…”
Section: Introductionmentioning
confidence: 99%